The relationship between maternal cannabis use disorder diagnosis and the development of retinopathy of prematurity
This study investigates the relationship between maternal cannabis use disorder diagnosis and the development of retinopathy of prematurity in preterm infants. Findings indicate no significant increase in retinopathy risk associated with maternal…
Delta-9-Tetrahydrocannabinol alleviates chemotherapy-induced weight loss but not colitis
Delta-9-tetrahydrocannabinol weight loss effects were studied in a preclinical model showing benefits against chemotherapy-induced weight loss. This research highlights THC's potential in managing weight loss during chemotherapy. However,…
Cannabidiol (CBD) Does Not Reduce Cocaine Reward in Schizophrenia Model
CBD schizophrenia substance use effects were tested in a mouse model of genetic susceptibility. The study found no reduction in cocaine reward or self-administration. These findings suggest limited efficacy of CBD for treating substance use in…
Parent and Caregiver Perceptions of Cannabidiol Products May Put Children at Risk
Pediatric cannabidiol exposure risks are rising alongside the growth of the CBD market. Understanding caregiver perceptions is critical to preventing unintentional exposure. This study highlights the need for improved safety education and childproof…
Assessment of Clinical Factors Predicting Nabilone Response for Agitation in Alzheimer’s
This study investigates nabilone response predictors in treating agitation in Alzheimer's disease. Researchers analyzed clinical factors influencing treatment outcomes. Understanding these predictors may guide personalized cannabinoid therapy for…
Investigating Cannabinoids for Inflammation and Sickle Cell Disease Pain
This protocol outlines a randomized controlled trial investigating dronabinol sickle cell disease pain management. The study evaluates cannabinoids for inflammation and pain reduction. It aims to provide evidence for safer alternatives to opioids in…
UK Medical Cannabis Registry: A clinical outcomes analysis for insomnia.
The UK medical cannabis registry insomnia outcomes reveal significant improvements in sleep quality for patients with primary insomnia. This clinical analysis highlights sustained benefits over 18 months. Anxiety and quality of life also showed positive…
Cannabidiol-Hyaluronic Acid Rectal Therapy for Abacterial Prostatitis Symptoms
This pilot study investigates cbd hyaluronic acid prostatitis therapy delivered rectally for chronic nonbacterial prostatitis. Results showed significant symptom improvement in patients. The study supports further research on this novel treatment…
Prevalence of Schizophrenia Spectrum and Bipolar Disorder Among Cannabis Induced Psychosis Patients
Cannabis induced psychosis risk is a critical clinical concern with significant implications for patient prognosis. This review provides prevalence data on progression to schizophrenia spectrum and bipolar disorder. Understanding this risk helps guide…
Feasibility and Acceptability of a Physical Activity Intervention to Reduce Prenatal Cannabis Use
This study evaluates a prenatal cannabis use intervention focused on physical activity to reduce cannabis consumption during pregnancy. The pilot trial demonstrated high feasibility and acceptability among participants. Results suggest potential for…